DLB
Dolby Laboratories
58.60$
+1.7%
vs. previous close
Closing price · As of: Sep 25, 2026
Statements
Balance Sheet
All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.
Tick rows to compare them in a chart (up to 4)
| Line item | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| – | -2.0% | +3.7% | -2.3% | +5.3% | +0.9% | +2.2% | -1.0% | +1.0% | -1.1% | +1.8% | -2.9% | |
| – | -2.4% | +6.9% | -5.4% | -18.7% | +7.7% | +8.0% | -3.7% | +3.7% | +1.4% | +0.5% | -6.3% | |
| – | -13.4% | +16.3% | -6.1% | -25.4% | +5.9% | +22.7% | -6.9% | +0.5% | -8.3% | -7.7% | +12.6% | |
| – | -11.2% | +10.7% | -3.6% | -36.2% | +5.9% | +22.7% | -6.8% | +0.5% | -8.3% | -7.7% | +12.7% | |
| – | +14.9% | +2.8% | -9.3% | +7.6% | +9.2% | -2.8% | -7.8% | +2.0% | +11.6% | +10.3% | -21.9% | |
| – | +5.5% | -4.7% | -3.0% | -2.8% | -5.6% | +8.7% | -6.3% | -6.1% | +2.8% | +2.1% | -3.6% | |
| – | – | – | – | – | -1.0% | -1.2% | +0.9% | -1.5% | -0.3% | – | – | |
| – | +0.5% | -0.4% | 0.0% | +30.5% | -2.4% | +0.9% | +0.7% | +0.2% | +0.1% | -0.1% | -0.3% | |
| – | -4.5% | -4.8% | -4.9% | +200.4% | -3.1% | -2.2% | -0.9% | -2.7% | -8.3% | +7.1% | -1.9% | |
| – | -7.9% | +5.9% | -13.3% | +22.3% | -0.3% | +0.7% | -9.9% | +2.4% | -1.1% | +5.6% | -9.4% | |
| – | -6.7% | +12.4% | -20.0% | +17.9% | +5.8% | +3.5% | -15.0% | +12.6% | +1.3% | +7.0% | -12.3% | |
| – | -5.2% | +9.9% | -11.5% | -2.6% | -6.6% | -5.7% | +1.6% | -5.2% | -0.6% | -4.4% | -0.1% | |
| – | -31.2% | +37.0% | -16.8% | +5.9% | -33.5% | +49.7% | -0.3% | +3.5% | -51.4% | +138.7% | -39.7% | |
| – | -0.4% | +3.2% | +0.5% | +1.8% | +1.2% | +2.6% | +1.2% | +0.7% | -1.1% | +0.9% | -1.3% | |
| – | -1.0% | +3.5% | +0.5% | +1.4% | +1.9% | +2.3% | +0.6% | +0.6% | -1.2% | +1.0% | -1.2% | |
| – | -0.2% | -0.6% | +0.1% | -0.4% | +0.6% | +0.3% | -0.6% | -0.1% | -0.3% | -1.0% | -1.0% |
Data as of: September 25, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.